ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802 · see citing works

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380 · see citing works

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339 · see citing works

Delaying the Empiric Treatment of <i>Candida</i> Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · see citing works

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205 · see citing works

Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.

Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · see citing works

A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,168 · see citing works

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039 · see citing works

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 905 · see citing works

Anidulafungin versus Fluconazole for Invasive Candidiasis

Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894 · see citing works

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases · doi:10.1086/524669 · Cited by 887 · see citing works

Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study

Slavin, M. A., Osborne, B., Adams, R. H., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 812 · see citing works

Candida Colonization and Subsequent Infections in Critically III Surgical Patients

Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798 · see citing works

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

van Burik, J. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 741 · see citing works

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692 · see citing works

Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months

Benjamin, D. K., Stoll, B. J., Fanaroff, A., McDonald, S. A., Oh, W., Higgins, R. D., Duara, S., Poole, W. K., Laptook, A. R., & Goldberg, R. N. (2006) · PEDIATRICS · doi:10.1542/peds.2004-2292 · Cited by 659 · see citing works

A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*

León, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659 · see citing works

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A. C., Bow, E. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 623 · see citing works

Fluconazole prophylaxis against fungal colonization and infection in preterm infants.

Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523 · see citing works

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Kullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521 · see citing works

Bovine Lactoferrin Supplementation for Prevention of Late-Onset Sepsis in Very Low-Birth-Weight Neonates A Randomized Trial

Manzoni, P. (2009) · JAMA · doi:10.1001/jama.2009.1403 · Cited by 520 · see citing works

Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial

Marr, K. A., Seidel, K. D., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 510 · see citing works

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects

Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495 · see citing works

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268151 · Cited by 478 · see citing works

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

Marr, K. A., Crippa, F., Leisenring, W. M., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2003) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 440 · see citing works

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

Prentice, H. G., Hann, I. M., Herbrecht, R., Aoun, M., Kvaløy, S., Catovsky, D., Pinkerton, R., Schey, S., Jacobs, F., Oakhill, A., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2473063.x · Cited by 437 · see citing works

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

WALSH, T. J., LUTSAR, I., DRISCOLL, T., DUPONT, B., RODEN, M., GHAHRAMANI, P., HODGES, M., GROLL, A. H., & PERFECT, J. R. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200203000-00015 · Cited by 431 · see citing works

Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial

Winston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., & Territo, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00006 · Cited by 388 · see citing works

Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment

Benjamin, D. K., Stoll, B. J., Gantz, M. G., Walsh, M. C., Sánchez, P. J., Das, A., Shankaran, S., Higgins, R. D., Auten, K. J., Miller, N. A., et al. (2010) · PEDIATRICS · doi:10.1542/peds.2009-3412 · Cited by 380 · see citing works

Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study

León, C., Ruiz‐Santana, S., Saavedra, P., Galván, B., Blanco, A., Castro, C., Balasini, C., Utande-Vázquez, A., de Molina, F. J. G., Blasco-Navalproto, M. A., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819daa14 · Cited by 375 · see citing works

Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System

Groll, A. H., Giri, N., Petraitis, V., Petraitienė, R., Candelario, M., Bacher, J., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373 · see citing works

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

Ostrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology &amp; Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369 · see citing works

A Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates

Manzoni, P., Stolfi, I., Pugni, L., Decembrino, L., Magnani, C., Vetrano, G., Tridapalli, E., Corona, G., Giovannozzi, C., Farina, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065733 · Cited by 355 · see citing works

Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration

Walsh, T. J., Karlsson, M. O., Driscoll, T., Arguedas, A. G., Adamson, P. C., Sáez‐Llorens, X., Vora, A. J., Arrieta, A. C., Blumer, J. L., Lutsar, I., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2166-2172.2004 · Cited by 337 · see citing works

Oral Supplementation with Lactobacillus casei Subspecies rhamnosus Prevents Enteric Colonization by Candida Species in Preterm Neonates: A Randomized Study

Manzoni, P., Mostert, M., Leonessa, M., Priolo, C., Farina, D., Monetti, C., Latino, M. A., & Gomirato, G. (2006) · Clinical Infectious Diseases · doi:10.1086/504324 · Cited by 305 · see citing works

Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy

Rotstein, C., Bow, E. J., Laverdière, M., Ioannou, S., Carr, D., Moghaddam, N., & The Canadian Fluconazole Prophylaxis Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515128 · Cited by 265 · see citing works

Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients

Glasmacher, A. G., Prentice, A. G., Gorschlüter, M., Engelhart, S., Hahn, C., Djulbegović, B., & Schmidt‐Wolf, I. G. H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.052 · Cited by 263 · see citing works

Itraconazole Oral Solution as Prophylaxis for Fungal Infections in Neutropenic Patients with Hematologic Malignancies: A Randomized, Placebo‐Controlled, Double‐Blind, Multicenter Trial

Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., Girmenia, C., Barbabietola, G., Pagano, L., Leoni, P., Specchia, G., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515129 · Cited by 244 · see citing works

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Seibel, N. L., Schwartz, C. L., Arrieta, A. C., Flynn, P. M., Shad, A. T., Albano, E., Keirns, J. J., Lau, W. M., Facklam, D., Buell, D. N., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3317-3324.2005 · Cited by 241 · see citing works

Fluconazole for Prophylaxis Against Candidal Rectal Colonization in the Very Low Birth Weight Infant

Kicklighter, S. D., Springer, S. C., Cox, T. H., Hulsey, T. C., & Turner, R. B. (2001) · PEDIATRICS · doi:10.1542/peds.107.2.293 · Cited by 239 · see citing works

Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma

Jang, S., Colangelo, P. M., & Gobburu, J. V. S. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.64 · Cited by 239 · see citing works

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Walsh, T. J., Adamson, P. C., Seibel, N. L., Flynn, P. M., Neely, M. N., Schwartz, C. L., Shad, A. T., Kaplan, S. L., Roden, M. M., Stone, J. A., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4536-4545.2005 · Cited by 238 · see citing works

Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-analytic Techniques

Benjamin, D. K., Poole, C., Steinbach, W. J., Rowen, J. L., & Walsh, T. J. (2003) · PEDIATRICS · doi:10.1542/peds.112.3.634 · Cited by 232 · see citing works

Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies

Karlsson, M. O., Lutsar, I., & Milligan, P. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00751-08 · Cited by 228 · see citing works

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

Troke, P. F., Hockey, H. P., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01083-10 · Cited by 217 · see citing works

Voriconazole Pharmacokinetics and Pharmacodynamics in Children

Neely, M. N., Rushing, T., Kovács, A., Jelliffe, R. W., & Hoffman, J. A. (2009) · Clinical Infectious Diseases · doi:10.1086/648679 · Cited by 214 · see citing works

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients(*)

Piarroux, R., Grenouillet, F., Balvay, P., Tran, V., Blasco, G., Millon, L., & Boillot, A. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000147726.62304.7f · Cited by 213 · see citing works

Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial

Schuster, M. G., Edwards, J. E., Sobel, J. D., Darouiche, R. O., Karchmer, A. W., Hadley, S., Slotman, G., Panzer, H., Biswas, P., & Rex, J. H. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00004 · Cited by 210 · see citing works

Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis

Queiroz‐Telles, F., Berezin, E. N., Leverger, G., Freire, A., van der Vyver, A., Chotpitayasunondh, T., Konja, J., Diekmann-Berndt, H., Koblinger, S., Groll, A. H., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817275e6 · Cited by 210 · see citing works

Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections

Benjamin, D. K., Driscoll, T., Seibel, N. L., Gonzalez, C. E., Roden, M. M., Kilaru, R., Clark, K., Dowell, J. A., Schranz, J., & Walsh, T. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.632-638.2006 · Cited by 209 · see citing works

Risk Factors and Predictors for Candidemia in Pediatric Intensive Care Unit Patients: Implications for Prevention

Zaoutis, T. E., Prasad, P. A., Localio, A. R., Coffin, S. E., Bell, L. M., Walsh, T. J., & Gross, R. (2010) · Clinical Infectious Diseases · doi:10.1086/655698 · Cited by 208 · see citing works

Caspofungin Therapy of Neonates With Invasive Candidiasis

ODIO, C. M., Araya, R., Pinto, L. E., Castro, C. E. F., Vasquez, S., Alfaro, B., Saenz, A. H., Herrera, M. L., & Walsh, T. J. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000145408.51526.0a · Cited by 196 · see citing works

The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants

Heresi, G. P., Gerstmann, D. R., Reed, M. D., van den Anker, J. N., Blumer, J. L., Kovanda, L. L., Keirns, J. J., Buell, D. N., & Kearns, G. L. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000245103.07614.e1 · Cited by 178 · see citing works

The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in Neonates

Hope, W. W., Mickiene, D., Petraitis, V., Petraitienė, R., Kelaher, A. M., Hughes, J. E., Cotton, M. P., Bacher, J., Keirns, J. J., Buell, D. N., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/524063 · Cited by 177 · see citing works

Population Pharmacokinetics of Fluconazole in Young Infants

Wade, K. C., Wu, D., Kaufman, D. A., Ward, R. M., Benjamin, D. K., Sullivan, J. E., Ramey, N., Jayaraman, B., Hoppu, K., Adamson, P. C., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00569-08 · Cited by 174 · see citing works

Fluconazole vs. Amphotericin B for the Treatment of Neonatal Fungal Septicemia: A Prospective Randomized Trial

Driessen, M., Ellis, J. B., Cooper, P. A., Wainer, S., Muwazi, F., Hahn, D., Gous, H., & Villiers, F. P. R. D. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199612000-00011 · Cited by 169 · see citing works

Bovine Lactoferrin Prevents Invasive Fungal Infections in Very Low Birth Weight Infants: A Randomized Controlled Trial

Manzoni, P., Stolfi, I., Messner, H., Cattani, S., Laforgia, N., Romeo, M. G., Bollani, L., Rinaldi, M., Gallo, E., Quercia, M., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2011-0279 · Cited by 169 · see citing works

Candidal Meningitis in Neonates: A 10-Year Review

Fernandez, M., Moylett, E. H., Noyola, D. E., & Baker, C. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313973 · Cited by 163 · see citing works

Twice Weekly Fluconazole Prophylaxis for Prevention of Invasive Candida Infection in High-risk Infants of <1000 Grams Birth Weight

Kaufman, D. A., Boyle, R. J., Hazen, K. C., Patrie, J. T., Robinson, M. L., & Grossman, L. B. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.036 · Cited by 161 · see citing works

Amphotericin B lipid complex in pediatric patients with invasive fungal infections

Walsh, T. J., Seibel, N. L., Arndt, C., et al. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199908000-00010 · Cited by 158 · see citing works

Posaconazole Plasma Concentrations in Juvenile Patients with Invasive Fungal Infection

Krishna, G., Sansone‐Parsons, A., Martinho, M., Kantesaria, B. S., & Pedicone, L. D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00454-06 · Cited by 155 · see citing works

Prophylactic Fluconazole Is Effective in Preventing Fungal Colonization and Fungal Systemic Infections in Preterm Neonates: A Single-Center, 6-Year, Retrospective Cohort Study

Manzoni, P., Arisio, R., Mostert, M., Leonessa, M., Farina, D., Latino, M. A., & Gomirato, G. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2227 · Cited by 151 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases

Ullmann, A. J., Cornely, O. A., DonneNy, J. P., Akova, M., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Billé, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12037 · Cited by 150 · see citing works

Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species

Healy, C. M., Campbell, J. R., Zaccaria, E., & Baker, C. J. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1130 · Cited by 149 · see citing works

Infections diagnosed in the first year after pediatric stem cell transplantation

Benjamin, D. K., Miller, W. C., Bayliff, S. L., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200203000-00013 · Cited by 146 · see citing works

Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates

Roilides, E., Farmaki, E., Evdoridou, J., Dotis, J., Hatziioannidis, E., Tsivitanidou, M., Bibashi, E., Filioti, I., Sofianou, D., Gil‐Lamaignere, C., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1210-9 · Cited by 142 · see citing works

Repeated-Dose Pharmacokinetics of an Oral Solution of Itraconazole in Infants and Children

de Repentigny, L., Ratelle, J., Leclerc, J.-M., Cornu, G., Sokal, E. M., Jacqmin, P., & de Beule, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.404 · Cited by 142 · cited 3× · see citing works

Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children

Walsh, T. J., Driscoll, T., Milligan, P. A., Wood, N., Schlamm, H. T., Groll, A. H., Jafri, H. S., Arrieta, A. C., Klein, N. J., & Lutsar, I. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00896-10 · Cited by 142 · see citing works

Invasive fungal infections in pediatric oncology

Mor, M., Gilad, G., Kornreich, L., Fisher, S., Yaniv, I., & Levy, I. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23005 · Cited by 138 · see citing works

A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia

Maertens, J. A., Madero, L., Reilly, A. F., Lehrnbecher, T., Groll, A. H., Jafri, H. S., Green, M., Nania, J. J., Bourque, M. R., Wise, B. A., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181da2171 · Cited by 137 · see citing works

Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age

Sáez‐Llorens, X., Macías-Parra, M., Maiya, P. P., Piñeros, J. G., Jafri, H. S., Chatterjee, A., Ruiz, G., Raghavan, J., Bradshaw, S. K., Kartsonis, N. A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00868-08 · Cited by 133 · see citing works

Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations

Linder, N. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg419 · Cited by 131 · see citing works

Population Pharmacokinetics of Micafungin in Neonates and Young Infants

Hope, W. W., Smith, P. B., Arrieta, A. C., Buell, D. N., Roy, M., Kaibara, A., Walsh, T. J., Cohen‐Wolkowiez, M., & Benjamin, D. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01679-09 · Cited by 127 · see citing works

Pharmacokinetics of Amphotericin B in Infants and Children

Starke, J. R., Mason, E. O., Kramer, W. G., & Kaplan, S. L. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.4.766 · Cited by 126 · see citing works

Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis

Groll, A. H., Wood, L., Roden, M., Mickiene, D., Chiou, C. C., Townley, E., Dad, L., Piscitelli, S. C., & Walsh, T. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2554-2563.2002 · Cited by 123 · see citing works

Impact of Fluconazole Prophylaxis on Incidence and Outcome of Invasive Candidiasis in a Neonatal Intensive Care Unit

Healy, C. M., Baker, C. J., Zaccaria, E., & Campbell, J. R. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.016 · Cited by 122 · see citing works

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial

Viscoli, C., Castagnola, E., Van Lint, M. T., Moroni, C., Garaventa, A., Rossi, M. R., Fanci, R., Menichetti, F., Caselli, D., Giacchino, M., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00619-2 · Cited by 122 · see citing works

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

Lee, J. W., Seibel, N. L., Amantea, M., Whitcomb, P., Pizzo, P. A., & Walsh, T. J. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81975-4 · Cited by 120 · see citing works

Fluconazole Loading Dose Pharmacokinetics and Safety in Infants

Piper, L., Smith, P. B., Hornik, C. P. V., Cheifetz, I. M., Barrett, J. S., Moorthy, G., Hope, W. W., Wade, K. C., Cohen‐Wolkowiez, M., & Benjamin, D. K. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318202cbb3 · Cited by 116 · see citing works

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial

Penack, O., Schwartz, S., Martus, P., Reinwald, M., Schmidt‐Hieber, M., Thiel, E., & Blau, I. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl128 · Cited by 116 · see citing works

Fluconazole Prophylaxis Prevents Invasive Fungal Infection in High-risk, Very Low Birth Weight Infants

Bertini, G., Perugi, S., Dani, C., Filippi, L., Pratesi, S., & Rubaltelli, F. F. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.02.020 · Cited by 112 · see citing works

High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates

Juster‐Reicher, A., Flidel‐Rimon, O., Amitay, M., Even-Tov, S., Shinwell, E., & Leibovitz, E. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0993-4 · Cited by 111 · see citing works

Targeted Short-Term Fluconazole Prophylaxis Among Very Low Birth Weight and Extremely Low Birth Weight Infants

Uko, S. E., Soghier, L. M., Vega, M., Marsh, J., Reinersman, G. T., Herring, L., Dave, V. A., Nafday, S. M., & Brion, L. P. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1969 · Cited by 110 · see citing works

Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal Dosing

Hope, W. W., Seibel, N. L., Schwartz, C. L., Arrieta, A. C., Flynn, P. M., Shad, A. T., Albano, E. A., Keirns, J. J., Buell, D. N., Gumbo, T., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00398-07 · Cited by 110 · see citing works

Epidemiology of paediatric invasive fungal infections and a case‐control study of risk factors in acute leukaemia or post stem cell transplant

Hale, K. A., Shaw, P. J., Dalla‐Pozza, L., MacIntyre, C. R., Isaacs, D., & Sorrell, T. C. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08072.x · Cited by 110 · see citing works

Population Pharmacokinetics of Amphotericin B Lipid Complex in Neonates

Würthwein, G., Groll, A. H., Hempel, G., Adler‐Shohet, F. C., Lieberman, J. M., & Walsh, T. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5092-5098.2005 · Cited by 108 · see citing works

Safety and Tolerability of Fluconazole in Children

Novelli, V. M., & Holzel, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1955 · Cited by 108 · see citing works

A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies

Ninane, J. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01974614 · Cited by 106 · see citing works

Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases

Hong, Y., Shaw, P. J., Nath, C. E., Yadav, S. P., Stephen, K. R., Earl, J. W., & McLachlan, A. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.935-942.2006 · Cited by 102 · see citing works

Prophylactic Oral Nystatin and Fungal Infections in Very-Low-Birthweight Infants

Sims, M. E., Yoo, Y., You, H., Salminen, C., & Walther, F. J. (1988) · American Journal of Perinatology · doi:10.1055/s-2007-999649 · Cited by 101 · see citing works

Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl‐β‐cyclodextrin oral solution or coated‐pellet capsules

Glasmacher, A. G., Hahn, C., Molitor, E., Marklein, G., Sauerbruch, T., & Schmidt‐Wolf, I. G. H. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00518.x · Cited by 101 · see citing works

Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis

Aghai, Z. H., Mudduluru, M., Nakhla, T., Amendolia, B., Longo, D., Kemble, N., Kaki, S., Sutsko, R. P., Saslow, J. G., & Stahl, G. E. (2006) · Journal of Perinatology · doi:10.1038/sj.jp.7211570 · Cited by 95 · see citing works

Liposomal Amphotericin B (AmBisome) in the Treatment of Neonatal Candidiasis in Very Low Birth Weight Infants

Juster‐Reicher, A., Leibovitz, E., Linder, N., Amitay, M., Flidel‐Rimon, O., Even-Tov, S., Mogilner, B. M., & Barzilai, A. (2000) · Infection · doi:10.1007/s150100070040 · Cited by 94 · see citing works

Pharmacokinetics of amphotericin B in children

Benson, J., & Nahata, M. C. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1989 · Cited by 91 · see citing works

Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures

Cohen‐Wolkowiez, M., Smith, P. B., Mangum, B., Steinbach, W. J., Alexander, B. D., Cotten, C. M., Clark, R. H., Walsh, T. J., & Benjamin, D. K. (2006) · Journal of Perinatology · doi:10.1038/sj.jp.7211628 · Cited by 89 · see citing works

Efficacy and Safety of Amphotericin B Lipid Complex in 548 Children and Adolescents With Invasive Fungal Infections

Wiley, J. M., Seibel, N. L., & Walsh, T. J. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000153183.51258.b8 · Cited by 89 · see citing works

Candida endophthalmitis in the premature infant

Baley, J. E., Annable, W. L., & Kliegman, R. M. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80722-6 · Cited by 86 · see citing works

Candida infection in pediatric liver transplant recipients

Gladdy, R. A., Richardson, S. E., Davies, H. D., & Superina, R. A. (1999) · Liver Transplantation and Surgery · doi:10.1002/lt.500050105 · Cited by 86 · see citing works

Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome®)

Weitkamp, J.-H., Poets, C. F., Sievers, R., Musswessels, E., Groneck, P., Thomas, P., & Bartmann, P. (1998) · Infection · doi:10.1007/bf02768745 · Cited by 86 · see citing works

Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit

Öztürk, M. A., Güneş, T., Köklü, E., Çetin, N., & Koç, N. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01274.x · Cited by 76 · see citing works

Posaconazole salvage treatment in paediatric patients: a multicentre survey

Lehrnbecher, T., Attarbaschi, A., Dürken, M., Garbino, J., Gruhn, B., Kontny, U., Lüer, S. C., Phillips, B., Scholz, J., Wagner, H. J., et al. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0957-4 · Cited by 76 · see citing works

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy Adults

Driscoll, T. A., Frangoul, H., Nemecek, E. R., Murphey, D., Yu, L. C., Blumer, J. L., Krance, R. A., Baruch, A. M., & Liu, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05010-11 · Cited by 74 · see citing works

Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates

Cohen‐Wolkowiez, M., Benjamin, D. K., Piper, L., Cheifetz, I. M., Moran, C., Liu, P., Aram, J. A., Kashuba, A. D. M., Capparelli, E. V., Walsh, T. J., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.26 · Cited by 73 · see citing works

Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants

Aydemir, C., Oğuz, Ş. S., Dizdar, E. A., Akar, M., Sarıkabadayı, Y. Ü., Saygan, S., Erdeve, Ö., & Dilmen, U. (2010) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2009.178996 · Cited by 73 · see citing works

Candidaemia in a European Paediatric University Hospital: a 10-year observational study

Tragiannidis, A., Fegeler, W., Rellensmann, G., Debus, V., Müller, V., Hoernig-Franz, I., Siam, K., Pana, Z. D., Jürgens, H., & Groll, A. H. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03720.x · Cited by 72 · see citing works

Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants

Austin, N. C., Cleminson, J. S., Darlow, B. A., & McGuire, W. L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003478.pub5 · Cited by 72 · see citing works

Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders

Foot, A., Veys, P., & Gibson, B. E. S. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702023 · Cited by 72 · see citing works

Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection

McCrossan, B., McHenry, E., O’Neill, F., Ong, G., & Sweet, D. G. (2007) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2006.094359 · Cited by 68 · see citing works

Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure

Weitkamp, J.-H., Ozdas, A., LaFleur, B., & Potts, A. L. (2008) · Journal of Perinatology · doi:10.1038/sj.jp.7211914 · Cited by 67 · see citing works

Challenging issues in neonatal candidiasis

Kaufman, D. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.487799 · Cited by 66 · see citing works

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults

Driscoll, T. A., Yu, L. C., Frangoul, H., Krance, R. A., Nemecek, E. R., Blumer, J. L., Arrieta, A. C., Graham, M. L., Bradfield, S. M., Baruch, A. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00531-11 · Cited by 64 · see citing works

Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place

Pasqualotto, A. C., de Moraes, A. B., Zanini, R. R., & Severo, L. C. (2007) · Infection Control &amp; Hospital Epidemiology · doi:10.1086/516658 · Cited by 60 · see citing works

Antifungal Chemoprophylaxis in Children and Adolescents with Haematological Malignancies and Following Allogeneic Haematopoietic Stem Cell Transplantation

Tragiannidis, A., Dokos, C., Lehrnbecher, T., & Groll, A. H. (2012) · Drugs · doi:10.2165/11599810-000000000-00000 · Cited by 60 · see citing works

Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection

Wainer, S., Cooper, P. A., FUNK, E., et al. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199209000-00008 · Cited by 59 · see citing works

Fluconazole Prophylaxis in Extremely Low Birth Weight Infants and Neurodevelopmental Outcomes and Quality of Life at 8 to 10 Years of Age

Kaufman, D. A., Cuff, A. L., Wamstad, J. B., Boyle, R. J., Gurka, M. J., Grossman, L. B., & Patrick, P. D. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.11.002 · Cited by 58 · see citing works

Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation

Kolve, H., Ahlke, E., Fegeler, W., Ritter, J., Jürgens, H., & Groll, A. H. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp196 · Cited by 56 · see citing works

Safety of Micafungin in Pediatric Clinical Trials

Arrieta, A. C., Maddison, P., & Groll, A. H. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182127eaf · Cited by 51 · see citing works

Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome

Mattiuzzi, G. N., Cortes, J. E., Alvarado, G. C., Verstovšek, S., Koller, C. A., Pierce, S. A., Blamble, D., Faderl, S., Xiao, L., Hernández, M., et al. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0783-3 · Cited by 51 · see citing works

Oral Voriconazole Versus Intravenous Low Dose Amphotericin B for Primary Antifungal Prophylaxis in Pediatric Acute Leukemia Induction

Mandhaniya, S., Swaroop, C., Thulkar, S. P., Vishnubhatla, S., Kabra, S. K., Xess, I., & Bakhshi, S. (2011) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3182331bc7 · Cited by 49 · see citing works

Update on antifungal agents for paediatric patients

Groll, A. H., & Tragiannidis, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03334.x · Cited by 48 · see citing works

Antifungal Prophylaxis in Solid-Organ Transplant Recipients: Considerations for Clinical Trial Design

Singh, N. (2004) · Clinical Infectious Diseases · doi:10.1086/421957 · Cited by 48 · see citing works

Invasive candidiasis in neonates and children

Roilides, E. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.01.017 · Cited by 47 · see citing works

Epidemiology of Bloodstream Infections in the First Year After Pediatric Lung Transplantation

Danziger‐Isakov, L. A., Sweet, S. C., DelaMorena, M., et al. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000157089.42020.41 · Cited by 44 · see citing works

Comparison of Fluconazole and Nystatin Oral Suspensions for Prophylaxis of Systemic Fungal Infection in Very Low Birthweight Infants

Violaris, K., Carbone, T., Bateman, D., et al. (2009) · American Journal of Perinatology · doi:10.1055/s-0029-1224871 · Cited by 42 · see citing works

Population pharmacokinetics of amphotericin B in children with malignant diseases

Nath, C. E., McLachlan, A. J., Shaw, P. J., et al. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01496.x · Cited by 41 · see citing works

Caspofungin for the treatment of azole resistant candidemia in a premature infant

Smith, P. B., Steinbach, W. J., Cotten, C. M., et al. (2007) · Journal of Perinatology · doi:10.1038/sj.jp.7211637 · Cited by 40 · see citing works

Anidulafungin for Neonatal Hematogenous Candida Meningoencephalitis: Identification of Candidate Regimens for Humans Using a Translational Pharmacological Approach

Warn, P. A., Livermore, J., Howard, S. J., Felton, T., Sharp, J., Gregson, L., Goodwin, J., Petraitienė, R., Petraitis, V., Cohen‐Wolkowiez, M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05826-11 · Cited by 40 · see citing works

SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS

Zaoutis, T. E., Lehrnbecher, T., Groll, A. H., Steinbach, W. J., Jafri, H. S., Maertens, J. A., Ngai, A. L., Chow, J. W., Taylor, A. F., Strohmaier, K. M., et al. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181af5a15 · Cited by 37 · see citing works

Systemic antifungal prophylaxis for very low birthweight infants: a systematic review

Clerihew, L., Austin, N. C., & McGuire, W. L. (2007) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2007.121962 · Cited by 35 · see citing works

Invasive candidosis in pediatric patients

Roilides, E., Kadiltsoglou, I., Zahides, D., et al. (1997) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1997.tb00597.x · Cited by 32 · see citing works

Posaconazole: The Case for Therapeutic Drug Monitoring

Howard, S. J., Felton, T., Gómez‐López, A., & Hope, W. W. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31823cdeac · Cited by 32 · see citing works

The treatment of systemic candidiasis in neonates with oral fluconazole

Driessen, M., Ellis, J. B., Muwazi, F., & Villiers, F. P. R. D. (1997) · Annals of Tropical Paediatrics · doi:10.1080/02724936.1997.11747897 · Cited by 30 · see citing works

Antifungal prophylaxis in neonates

Manzoni, P., Jacqz-Aigrain, É., Rizzollo, S., Franco, C., Stronati, M., Mostert, M., & Farina, D. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.01.013 · Cited by 30 · see citing works

Treatment of candidal infections with fluconazole in neonates and infants.

Schwarze, R., Penk, A., & Pittrow, L. B. (2000) · PubMed · Cited by 29 · see citing works

Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT

Molina, J. R., Serrano, J., Sánchez‐García, J., Rodríguez-Villa, A., Gómez, P., Tallón, D., Martín, V., Rodriguez, G., Rojas, R., Martín, C., et al. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.111 · Cited by 29 · see citing works

Caspofungin for Refractory Candidemia in Neonates

Manzar, S., Kamat, M., & Pyati, S. P. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000200141.46957.71 · Cited by 25 · see citing works

Fluconazole Prophylaxis Decreases the Combined Outcome of Invasive Candida Infections or Mortality in Preterm Infants

Kaufman, D. A. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1837 · Cited by 24 · see citing works

Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants

Austin, N. C., Darlow, B. A., & McGuire, W. L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003478.pub3 · Cited by 24 · see citing works

Prävention von Pilzinfektionen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen

Groll, A. H., Ritter, J., & Müller, F. ‐. C. (2001) · Klinische Pädiatrie · doi:10.1055/s-2001-17502 · Cited by 24 · see citing works

ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases.

Ullman, A. J., Cornely, O. A., Donnelly, P., et al. (2012) · Radboud Repository (Radboud University) · Cited by 5 · see citing works

Anidulafungin vs. Fluconazole for Invasive Candidiasis

Ampel, N. M. (2007) · Journal watch · doi:10.1056/id200706130000001 · Cited by 1 · see citing works

Untitled work

Walsh (1995) · doi:10.1002/1097-0142(19951201)76:11

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556 · see citing works

Changes in the epidemiological landscape of invasive candidiasis

Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547 · see citing works

Mechanisms of echinocandin antifungal drug resistance

Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works

The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug

Mesa-Arango, A. C., Trevijano-Contador, N., Román, E., Sánchez-Fresneda, R., Casas, C., Herrero, E., Argüelles, J. C., Pla, J., Cuenca-Estrella, M., & Zaragoza, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03570-14 · Cited by 232 · see citing works

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206 · see citing works

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129 · see citing works

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern

Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125 · see citing works

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101 · see citing works

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99 · see citing works

Differential activity of the oral glucan synthase inhibitor SCY-078 against wild-type and echinocandin-resistant strains of Candida species

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Borroto-Esoda, K., & Castanheira, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00161-17 · Cited by 84 · see citing works

Antifungals in Clinical Use and the Pipeline

Johnson, M. D. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.005 · Cited by 35 · see citing works

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying <i>FKS</i> Mutant Candida glabrata Strains and Echinocandin Resistance

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-13 · Cited by 56 · see citing works

Fungal infections today: size of the problem and focus on the initial cost of therapy with echinocandin

Venditti, M. (2010) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v11i2.181

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

Tóth, Z., Forgács, L., Kardos, T., Kovács, R., Locke, J. B., Kardos, G., Nagy, F., Borman, A. M., Adnan, A., & Majoros, L. (2020) · Journal of Fungi · doi:10.3390/jof6030136 · Cited by 20 · see citing works

Serum Differentially Alters the Antifungal Properties of Echinocandin Drugs

Paderu, P., García‐Effrón, G., Balashov, S. V., Delmas, G., Park, S., & Perlin, D. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01536-06 · Cited by 109 · see citing works

In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates

Bordallo-Cardona, M. Á., Escribano, P., de la Pedrosa, E. G. G., Marcos-Zambrano, L. J., Cantón, R., Bouza, E., & Guinea, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01542-16 · Cited by 32 · see citing works